News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

DiaGenic ASA Presents New Data for Differentiating Alzheimer’s Disease Dementia From Other Forms of Dementia With High Accuracy



11/8/2012 9:59:17 AM

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: DiaGenic (OSE:DIAG): New results from re-evaluation of two separate and previously performed clinical trials show that DiaGenic’s technology has the potential to differentiate dementia due to Alzheimer’s disease (AD) from other forms of dementia. In one study, which included 103 patients with AD and 40 patients with other types of dementia and related disorders, AD was correctly identified and separated from other types of dementia with an accuracy of 89%. In a second study which included 25 patients with AD and 30 patients with other types of dementia, the diagnostic accuracy was 82%.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES